European Union · Question · QUESTION_WRITTEN
E-9-2021-002707
Conditions of contracts signed with pharmaceutical companies/consortia for the development and acquisition of vaccines against Covid-19 (IV)
Introduced
19 May 2021
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 August 2021
Records
Official question E-9-2021-002707 from European Union at European Parliament. Dated 19 May 2021. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Terms and conditions of the agreements concluded with pharmaceutical companies/consortia for the development and purchase of COVID‑19 vaccines (IV)
QUESTION_WRITTEN · EN · 31 May 2021
Terms and conditions of the agreements concluded with pharmaceutical companies/consortia for the development and purchase of COVID‑19 vaccines (IV)
QUESTION_WRITTEN · EN · 31 May 2021
Terms and conditions of the agreements concluded with pharmaceutical companies/consortia for the development and purchase of COVID‑19 vaccines (IV)
QUESTION_WRITTEN · EN · 31 May 2021
Answer
QUESTION_WRITTEN_ANSWER · 13 August 2021
Condições dos contratos celebrados com empresas/consórcios farmacêuticos para desenvolvimento e aquisição de vacinas contra a Covid-19 (IV)
QUESTION_WRITTEN · PT · 31 May 2021
Condições dos contratos celebrados com empresas/consórcios farmacêuticos para desenvolvimento e aquisição de vacinas contra a Covid-19 (IV)
QUESTION_WRITTEN · PT · 31 May 2021
Condições dos contratos celebrados com empresas/consórcios farmacêuticos para desenvolvimento e aquisição de vacinas contra a Covid-19 (IV)
QUESTION_WRITTEN · PT · 31 May 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.